cabozantinib,atezolizumab
exelixis,roche
['atezolizumab', 'bladder', 'cabozantinib', 'cosmic-021']
#asco22 presents results from cosmic-021 bladder cancer cohorts rx with cabozantinib + atezolizumab design, orrs, conclusions clinical activity present. giving shoutout to pioneering work of 
Medical Oncologist. Editor-in-chief: @ASCO Daily News; Presidential Endowed Chair, @HuntsmanCancer (NCI-CCC) @UUtah, FCOI https://t.co/qcdl195o3E